A Meta-Analytical Framework to Include Historical Data in Allometric Scaling

References

• Bonate , P. L. and Howard , D. 2000 . “Critique of Prospective Allometrics Scaling: Does the Emperor Have Clothes?” . Journal of Clinical Pharmacology , 40 : 335 – 340 .
   PubMed Web of Science ®Google Scholar
• Cosson , V. F. , Fueau , E. , Efthymiopoulos , C. and Bye , A. 1997 . “Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development. I: Interspecies Allometric Scaling,” . Journal of Pharmacokinetics and Biopharmaceutics , 25 ( 2 ) : 149 – 167 .
   Google Scholar
• De Buck , S , Sinha , V. K. , Fenu , L. A. , Nijsen , M. J. , Mackie , C. E. and Gilissen , R. A. 2007 . “Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Test Drugs,” . Drug Metabolism and Disposition , 35 : 1766 – 1788 .
   PubMed Web of Science ®Google Scholar
• Mahmood , I. 2000a . “Prospective Allometric Scaling: Does the Emperor Have Clothes?” . Journal of Clinical Pharmacology , 40 : 341 – 343 .
   Google Scholar
• Mahmood , I. 2000b . “Interspecies Scaling: Role of Protein Binding in the Prediction of Clearance From Animals to Humans,” . Journal of Clinical Pharmacology , 40 : 1439 – 1446 .
   PubMed Web of Science ®Google Scholar
• Mahmood , I. 2002 . “Interspecies Scaling: Predicting Oral Clearance in Humans,” . American Journal of Therapeutics , 9 : 35 – 42 .
   PubMedGoogle Scholar
• Mahmood , I. 2005 . Interspecies Pharmacokinetic Scaling—Principles and Application of Allometric Scaling , Rockville , MD : Pine House Publishers .
   Google Scholar
• Mahmood , I. and Balain , J. 1996 . “Interspecies Scaling: Predicting Clearance of Drugs in Humans. Three Different Approaches,” . Xenobiotica , 26 : 887 – 895 .
   PubMed Web of Science ®Google Scholar
• Molenberghs , G. and Kenward , M. G. 2007 . Missing Data in Clinical Studies , Chichester : Wiley .
   Google Scholar
• Nestorov , I. 2003 . “Whole Body Phamacokinetic Models,” . Clinical Pharmacokinetics , 42 ( 10 ) : 883 – 908 .
   PubMed Web of Science ®Google Scholar
• Rowland , M. , Balant , L. and Peck , C. 2004 . “Physiologically Based Pharmacokinetics in Drug Development and Regulatory Science: A Workshop Report (Georgetown University, Washington, DC, May 29–30, 2002),” . AAPS Pharm Science , 6 ( 1 ) : 1 – 12 .
   Google Scholar
• Sacher , V. 1959 . “Relationship of Lifespan to Brain Weight and Body Weight in Mammals,” . In CIBA Foundation Colloquia on Aging , Edited by: Wolstenholme , G. E. W. and O’Connor , M. 115 – 133 . London : Churchill .
   Google Scholar
• Sinha , V. K. , De Buck , S. S. , Fenu , L. A. , Smit , J. W. , Nijsen , M. , Gilissen , R. A. , Van Peer , A. , Lavrijsen , K. and Mackie , C. E. 2008 . “Predicting Oral Clearance in Humans. How Close Can We Get With Allometry?” . Clinical Pharmacokinetics , 47 ( 1 ) : 35 – 45 .
   PubMed Web of Science ®Google Scholar
• Van de Waterbeemd , H. and Gifford , E. 2003 . “ADMET in Silico Modelling: Towards Prediction Paradise?” . Nature Reviews—Drug Discovery , 2 : 192 – 204 .
   PubMed Web of Science ®Google Scholar
• Verbeke , G. and Molenberghs , G. 2000 . Linear Mixed Models in Practice a SAS-Oriented Approach , New York : Springer .
   Google Scholar
• Zhao , P. , Zhang , L. , Grillo , J. A. , Liu , Q. , Bullock , J. M. , Moon , Y. J. , Song , P. , Brar , S. S. , Madabushi , R. , Wu , T. C. , Booth , B. P. , Rahman , N. A. , Reynolds , K. S. , Gil Berglund , E. , Lesko , L. J. and Huang , S-M. 2010 . “Application of Physiologically Based Pharmacokinetics (PBPK) Modeling and Simulation During Regulatory Review,” . Clinical Pharmacology and Therapeutics , 89 : 259 – 267 .
   PubMed Web of Science ®Google Scholar